Blood-brain barrier transport mechanisms for antibody therapeutics¶
Analysis ID: SDA-2026-04-01-gap-008
Date: 2026-04-02
Domain: neurodegeneration
Hypotheses Generated: 7
Knowledge Graph Edges: 20
Key Hypotheses¶
- Synthetic Biology BBB Endothelial Cell Reprogramming (score: 0.557)
- Glymphatic System-Enhanced Antibody Clearance Reversal (score: 0.525)
- Circadian-Synchronized LRP1 Pathway Activation (score: 0.517)
- Dual-Domain Antibodies with Engineered Fc-FcRn Affinity Modulation (score: 0.513)
- Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides (score: 0.485)
- Magnetosonic-Triggered Transferrin Receptor Clustering (score: 0.453)
- Piezoelectric Nanochannel BBB Disruption (score: 0.405)
This notebook presents a computational analysis including differential gene expression, pathway enrichment, and multi-dimensional hypothesis scoring. Data is simulated based on known biology from the Allen Brain Cell Atlas (SEA-AD) and published literature.
1. Setup and Data Generation¶
Generated expression data for 20 genes x 5 cell types Samples per condition: 50 Primary cell type: Endothelial
2. Differential Expression Heatmap¶
Log2 fold change of gene expression between disease and control samples across cell types. Significance: * p<0.05, ** p<0.01, *** p<0.001 (Mann-Whitney U test).
Significant changes (p < 0.05): 13 / 100
3. Volcano Plot: Endothelial Expression¶
Differential expression in endothelial — the primary cell type of interest for this analysis. Red = upregulated in disease, blue = downregulated. Dashed line = p=0.05 threshold.
Significantly upregulated: 4 Significantly downregulated: 5
4. Statistical Analysis¶
Comprehensive statistical testing including non-parametric Mann-Whitney U tests, effect sizes (Cohen's d), and one-way ANOVA for cell-type variation.
====================================================================== STATISTICAL ANALYSIS SUMMARY ====================================================================== Significant results (p < 0.05): 13 gene-cell type pairs Gene Cell_Type Log2FC P_value Cohens_d Effect VCAM1 Endothelial 1.119583 1.518073e-09 1.358619 Large ANGPT2 Endothelial 1.111827 1.032405e-08 1.192858 Large VEGFA Endothelial 0.934845 4.267594e-07 0.930785 Large ICAM1 Endothelial 1.030700 1.574457e-06 1.068664 Large ANGPT1 Pericytes 1.044885 2.142450e-06 0.950917 Large PDGFRB Pericytes 0.997604 3.550548e-06 0.948672 Large MFSD2A Endothelial -0.593074 7.266301e-05 -0.755564 Medium SLC2A1 Endothelial -0.572285 8.635924e-05 -0.604820 Medium CLDN5 Endothelial -0.628513 8.886674e-05 -0.871067 Large TJP1 Endothelial -0.577566 2.289302e-04 -0.779376 Medium OCLN Endothelial -0.583995 2.482435e-04 -0.721795 Medium AQP4 Astrocytes -0.499423 3.509708e-04 -0.764879 Medium SLC2A1 Pericytes 0.318007 2.111160e-02 0.516251 Medium ====================================================================== ONE-WAY ANOVA: Expression Variation Across Cell Types (Disease) ====================================================================== TFRC F= 0.65 p=6.28e-01 ns LRP1 F= 0.89 p=4.70e-01 ns PECAM1 F= 1.00 p=4.10e-01 ns CDH5 F= 1.88 p=1.14e-01 ns CLDN5 F= 8.55 p=1.79e-06 *** OCLN F= 6.74 p=3.68e-05 *** TJP1 F= 4.37 p=1.98e-03 ** ====================================================================== MULTIPLE TESTING CORRECTION (Bonferroni) ====================================================================== Tests performed: 13 Significant before correction: 13 Significant after Bonferroni: 12
5. Pathway Enrichment Analysis¶
Hypergeometric test for enrichment of analysis target genes in curated biological pathways (Reactome/KEGG-style). Identifies which molecular processes are overrepresented.
Pathway Enrichment Results:
Pathway Overlap Overlap_Genes Fold_Enrichment P_value Significant
Tight Junction Assembly 3 OCLN, CLDN5, TJP1 1428.6 5.248425e-10 True
Receptor-Mediated Transcytosis 2 TFRC, LRP1 952.4 1.574029e-06 True
Lipid Transport 1 LRP1 571.4 1.748950e-03 True
ABC Transporter Efflux 0 - 0.0 1.000000e+00 False
VEGF Signaling 0 - 0.0 1.000000e+00 False
Pericyte-Endothelial Interaction 0 - 0.0 1.000000e+00 False
Neuroinflammatory BBB Disruption 0 - 0.0 1.000000e+00 False
Glucose Transport 0 - 0.0 1.000000e+00 False
6. Hypothesis Multi-Dimensional Scoring¶
Top hypotheses scored across 6 key dimensions: mechanistic plausibility, evidence strength, novelty, feasibility, therapeutic impact, and druggability.
7. Knowledge Graph Edges¶
Causal relationships extracted from the multi-agent debate:
| Source | Relation | Target | Confidence |
|---|---|---|---|
| TFR1 | associated_with | neurodegeneration | 0.648 |
| TFR1 | interacts_with | LRP1 | 0.648 |
| TFR1 | interacts_with | CAV1 | 0.648 |
| TFR1 | interacts_with | ABCB1 | 0.648 |
| LRP1 | associated_with | neurodegeneration | 0.648 |
| LRP1 | interacts_with | TFR1 | 0.648 |
| LRP1 | interacts_with | CAV1 | 0.648 |
| LRP1 | interacts_with | ABCB1 | 0.648 |
| CAV1 | associated_with | neurodegeneration | 0.648 |
| CAV1 | interacts_with | TFR1 | 0.648 |
| CAV1 | interacts_with | LRP1 | 0.648 |
| CAV1 | interacts_with | ABCB1 | 0.648 |
| ABCB1 | associated_with | neurodegeneration | 0.648 |
| ABCB1 | interacts_with | TFR1 | 0.648 |
| ABCB1 | interacts_with | LRP1 | 0.648 |
| ABCB1 | interacts_with | CAV1 | 0.648 |
| FCGRT | associated_with | neurodegeneration | 0.532 |
| LRP1 | interacts_with | MTNR1A | 0.533 |
| LRP1 | interacts_with | MTNR1B | 0.533 |
| MTNR1A | associated_with | neurodegeneration | 0.533 |
Total edges: 20
Methodology¶
This analysis was generated by SciDEX's multi-agent scientific debate system:
- Theorist generates novel hypotheses based on known biology
- Skeptic challenges assumptions and identifies weaknesses
- Domain Expert assesses druggability, feasibility, and clinical relevance
- Synthesizer ranks hypotheses and extracts knowledge graph edges
Gene expression data is simulated based on published SEA-AD atlas findings (Allen Institute for Brain Science).
Generated: 2026-04-02 22:03 UTC Platform: SciDEX Source: GitHub